Navigation Links
Is Earlier Detection of Cancers Such as Glioma Possible?
Date:5/21/2008

BOSTON, May 21 /PRNewswire/ -- Oncolab, Inc.'s AMAS(R) Test (http://www.oncolabinc.com) is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-specific antibody, the Anti-malignin antibody, in human serum.

Anti-malignin is a normal antibody in humans which has been found to increase with age, as the risk of cancer increases. During the early stages of cancer, Anti-malignin antibody increases markedly in concentration.

Determining the concentration of this antibody is the basis for the AMAS Test for early detection of cancer. This test was first used to aid in the diagnosis of brain cancer, and was then found to be applicable to other common cancers because the glioma peptide contains a structural characteristic that is shared by other malignant cells.

After early detection of cancers with the aid of the AMAS Test, additional diagnostic techniques can be employed to establish a diagnosis, and surgery or other standard therapeutic techniques can be employed to treat the malignancy. Oncolab, Inc., the company that has developed the AMAS Test, was recently granted additional patent claims covering advances in its antibody and antigen detection techniques, as well as potential vaccine applications of the technology.

Press Contact:

Kevin Walsh

kwalsh@oncolabinc.com

617-536-0850

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Oncolab, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
2. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
3. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
4. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
5. Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
6. International Substance Detection Firm IDenta To Release New Lead Test Kit - Rash Of Toy Incidents Leads Company To Enter New Marketplace
7. iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology
8. The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
9. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
10. DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
11. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... Crucial Life Sciences Data Solutions, ... greatly improves performance of the platform. In particular, Version 4.1 boosts performance for ... data to be collected on a per patient basis. Clinical Studio has employed ...
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. (API) announced ... Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies for BioPlus® ... hydrophobic nanocellulose compositions. In addition to these patents and U.S. Patent No. ...
(Date:5/4/2016)... , ... May 05, 2016 , ... ... proud to support the National Stroke Association during National Stroke Awareness Month in ... Facebook and Twitter pages throughout the month. CereScan will donate $1 up ...
(Date:5/4/2016)... WHIPPANY, N.J. , May 4, 2016 /PRNewswire/ ... evaluating its oncology compound Stivarga ® (regorafenib) ... hepatocellular carcinoma (HCC) has met its primary endpoint ... The study, called RESORCE, evaluated the efficacy and ... disease has progressed after treatment with sorafenib. The ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):